000 | 01970 a2200529 4500 | ||
---|---|---|---|
005 | 20250516112546.0 | ||
264 | 0 | _c20121016 | |
008 | 201210s 0 0 rus d | ||
022 | _a0235-2990 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBogomolova, N S | |
245 | 0 | 0 |
_a[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula]. _h[electronic resource] |
260 |
_bAntibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] _c2012 |
||
300 |
_a18-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetamides _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aCandida _xdrug effects |
650 | 0 | 4 | _aCefepime |
650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
650 | 0 | 4 |
_aCiprofloxacin _xtherapeutic use |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIatrogenic Disease |
650 | 0 | 4 |
_aImipenem _xtherapeutic use |
650 | 0 | 4 |
_aIntubation, Intratracheal _xadverse effects |
650 | 0 | 4 | _aLinezolid |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMonitoring, Physiologic |
650 | 0 | 4 |
_aOxazolidinones _xtherapeutic use |
650 | 0 | 4 |
_aPolymyxin B _xtherapeutic use |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 |
_aStaphylococcus epidermidis _xdrug effects |
650 | 0 | 4 |
_aTracheoesophageal Fistula _xcomplications |
650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
700 | 1 | _aParshin, V D | |
700 | 1 | _aVishnevskaia, G A | |
700 | 1 | _aBol'shakov, L V | |
700 | 1 | _aKuznetsova, S M | |
773 | 0 |
_tAntibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] _gvol. 57 _gno. 3-4 _gp. 18-24 |
|
999 |
_c22119239 _d22119239 |